Teacher Retirement System of Texas Buys 4,790 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Teacher Retirement System of Texas raised its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 25.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,829 shares of the company's stock after buying an additional 4,790 shares during the quarter. Teacher Retirement System of Texas' holdings in HealthEquity were worth $2,106,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC grew its position in shares of HealthEquity by 24.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock valued at $564,000 after purchasing an additional 1,265 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of HealthEquity by 7,983.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock valued at $2,179,000 after purchasing an additional 24,350 shares in the last quarter. GAMMA Investing LLC grew its position in shares of HealthEquity by 25.9% in the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock valued at $139,000 after purchasing an additional 323 shares in the last quarter. Pier Capital LLC purchased a new position in shares of HealthEquity in the fourth quarter valued at $8,024,000. Finally, HighTower Advisors LLC grew its position in shares of HealthEquity by 4.8% in the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock valued at $9,122,000 after purchasing an additional 4,370 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 291,744 shares of company stock valued at $32,705,007. Insiders own 1.50% of the company's stock.

HealthEquity Price Performance

Shares of HQY traded down $2.67 during midday trading on Friday, reaching $94.52. The stock had a trading volume of 1,106,970 shares, compared to its average volume of 868,962. The company's 50-day moving average is $100.98 and its 200 day moving average is $98.43. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $8.17 billion, a price-to-earnings ratio of 68.99, a price-to-earnings-growth ratio of 1.45 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same period in the prior year, the business earned $0.80 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the subject of several recent analyst reports. Bank of America boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday. Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada boosted their target price on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Finally, Barrington Research boosted their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $118.55.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.